OBJECTIVES Hypertension (HTN) is a severe public health issue across the globe and a major risk factor for various cardiovascular diseases. This study was aimed to examine the potential costs of prognostic utilities and direct and indirect healthcare costs of the treatment of HTN in patients visiting public hospitals in Pakistan. METHODS A cross-sectional, convenient-sampling oriented study was conducted in patients attending public hospitals in Pakistan. The direct and indirect healthcare costs were assessed by different variables i.e. consultation fees, cost of medicines, travelling costs, laboratory test expenses. All obtained data were analyzed using descriptive and inferential statistics. RESULTS The mean annual direct healthcare cost for a HTN patient was around PKRs. 19789.88 (US$ 201.21) and indirect healthcare cost was PKRs. 11990.90 (US$ 121.92). It was also observed that the mean indirect healthcare costs per patient were significantly varied (p < 0.001) among different public hospitals. CONCLUSIONS Type of the HTN, distance to the hospital and length of stay in the hospital were proportional to the direct and indirect healthcare costs of the HTN patients. Better management of HTN can favorably impact the disease burden as untreated HTN or its comorbidities increase the overall treatment costs which affect affordability of the patient.